1. THU0395 Tumour necrosis factor-alpha as a master regulator of inflammation in erdheim-chester disease: Rationale for the successful treatment of two patients with infliximab. (23rd January 2014) Authors: Dagna, L.; Corti, A.; Langheim, S.; Guglielmi, B.; Cavalli, G.; De Cobelli, F.; Doglioni, C.; Fragasso, G.; Sabbadini, M.G.; Ferrarini, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗